Antomin is a new type of lipid-lowering drug, which can treat hypertriglyceridemia by inhibiting triglyceride synthesis and promoting triglyceride excretion, as well as treating atherosclerosis and preventing thrombosis, and can be applied to cardiovascular and cerebrovascular diseases, such as coronary atherosclerotic heart disease and cerebral infarction. Patients taking this drug may experience gastrointestinal symptoms such as nausea, abdominal distension, loss of appetite, etc. Dosing should start with the smallest dose and gradually increase to the therapeutic dose. This drug is excreted by the kidneys and should be used with discretion by those with renal insufficiency. Patients with cardiovascular disease should take a low-salt, low-fat diet, pay attention to rest, moderate exercise, monitor blood pressure and blood glucose, regularly review liver function, kidney function and coagulation index, and adjust drug doses according to laboratory results.